Latest News of RPRX
Why Is Royalty Pharma plc (RPRX) the Best Defensive Stock to Buy Now?
By Yahoo! Finance |
3 months ago
The article discusses the top defensive stocks to invest in, highlighting Royalty Pharma plc (NASDAQ:RPRX) as a leading choice. Royalty Pharma specializes in biopharmaceutical royalties and has a stro...
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
By Yahoo! Finance |
3 months ago
Royalty Pharma PLC (NASDAQ:RPRX) faces threats from intense competition and regulatory changes, impacting future earnings. Despite this, the company's financial health is strong, with a diversified ro...
Should You Consider Adding Royalty Pharma plc (RPRX) to Your Portfolio?
By Yahoo! Finance |
3 months ago
Patient Capital Management's Q2 2024 investor letter discusses the underperformance of its strategy compared to the S&P 500, attributing it to allocation and interaction effects. It mentions Royalty P...
-
Royalty Pharma (NASDAQ:RPRX) Is Due To Pay A Dividend Of $0.21
By Yahoo! Finance | 4 months agoRoyalty Pharma plc (NASDAQ:RPRX) will pay a dividend of $0.21 per share, exceeding the industry average at a 3.0% yield....
-
Is Royalty Pharma plc (RPRX) a Good Stock to Buy Now?
By Yahoo! Finance | 4 months agoThe article discusses undervalued stocks and highlights Royalty Pharma plc (NASDAQ:RPRX) as a promising investment due to its acquisition of frexalimab, which has significant market potential. The com...
-
Royalty Pharma plc (NASDAQ:RPRX) is largely controlled by institutional shareholders who own 70% of the company
By Yahoo! Finance | 5 months agoInstitutional investors hold 70% stake in Royalty Pharma, giving them significant influence. With 9 major shareholders owning 51%, individual investors also have a say. Analyst forecasts and insider o...